120 related articles for article (PubMed ID: 19723568)
1. Amelioration of endothelial damage/dysfunction is a possible mechanism for the neuroprotective effects of Rho-kinase inhibitors against ischemic brain damage.
Satoh S; Hitomi A; Ikegaki I; Kawasaki K; Nakazono O; Iwasaki M; Mohri M; Asano T
Brain Res Bull; 2010 Jan; 81(1):191-5. PubMed ID: 19723568
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection.
Rikitake Y; Kim HH; Huang Z; Seto M; Yano K; Asano T; Moskowitz MA; Liao JK
Stroke; 2005 Oct; 36(10):2251-7. PubMed ID: 16141422
[TBL] [Abstract][Full Text] [Related]
3. Wide therapeutic time window for Rho-kinase inhibition therapy in ischemic brain damage in a rat cerebral thrombosis model.
Satoh S; Toshima Y; Hitomi A; Ikegaki I; Seto M; Asano T
Brain Res; 2008 Feb; 1193():102-8. PubMed ID: 18187127
[TBL] [Abstract][Full Text] [Related]
4. A new model of cerebral microthrombosis in rats and the neuroprotective effect of a Rho-kinase inhibitor.
Toshima Y; Satoh S; Ikegaki I; Asano T
Stroke; 2000 Sep; 31(9):2245-50. PubMed ID: 10978059
[TBL] [Abstract][Full Text] [Related]
5. Improvement of cognitive deficit and neuronal damage in rats with chronic cerebral ischemia via relative long-term inhibition of rho-kinase.
Huang L; He Z; Guo L; Wang H
Cell Mol Neurobiol; 2008 Aug; 28(5):757-68. PubMed ID: 17554619
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological profile of hydroxy fasudil as a selective rho kinase inhibitor on ischemic brain damage.
Satoh S; Utsunomiya T; Tsurui K; Kobayashi T; Ikegaki I; Sasaki Y; Asano T
Life Sci; 2001 Aug; 69(12):1441-53. PubMed ID: 11531167
[TBL] [Abstract][Full Text] [Related]
7. Antivasospastic effects of hydroxyfasudil, a Rho-kinase inhibitor, after subarachnoid hemorrhage.
Satoh S; Takayasu M; Kawasaki K; Ikegaki I; Hitomi A; Yano K; Shibuya M; Asano T
J Pharmacol Sci; 2012; 118(1):92-8. PubMed ID: 22186620
[TBL] [Abstract][Full Text] [Related]
8. Fasudil, a Rho kinase (ROCK) inhibitor, protects against ischemic neuronal damage in vitro and in vivo by acting directly on neurons.
Yamashita K; Kotani Y; Nakajima Y; Shimazawa M; Yoshimura S; Nakashima S; Iwama T; Hara H
Brain Res; 2007 Jun; 1154():215-24. PubMed ID: 17482584
[TBL] [Abstract][Full Text] [Related]
9. Rho-kinase inhibition acutely augments blood flow in focal cerebral ischemia via endothelial mechanisms.
Shin HK; Salomone S; Potts EM; Lee SW; Millican E; Noma K; Huang PL; Boas DA; Liao JK; Moskowitz MA; Ayata C
J Cereb Blood Flow Metab; 2007 May; 27(5):998-1009. PubMed ID: 17033691
[TBL] [Abstract][Full Text] [Related]
10. Rho-kinase inhibitor prevents acute injury against transient focal cerebral ischemia by enhancing the expression and function of GABA receptors in rats.
Huang L; Li Q; Wen R; Yu Z; Li N; Ma L; Feng W
Eur J Pharmacol; 2017 Feb; 797():134-142. PubMed ID: 28109911
[TBL] [Abstract][Full Text] [Related]
11. Long-term inhibition of Rho-kinase restores the LTP impaired in chronic forebrain ischemia rats by regulating GABAA and GABAB receptors.
Huang L; Zhao LB; Yu ZY; He XJ; Ma LP; Li N; Guo LJ; Feng WY
Neuroscience; 2014 Sep; 277():383-91. PubMed ID: 25050822
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective properties of a protein kinase inhibitor against ischaemia-induced neuronal damage in rats and gerbils.
Satoh S; Ikegaki I; Suzuki Y; Asano T; Shibuya M; Hidaka H
Br J Pharmacol; 1996 Aug; 118(7):1592-6. PubMed ID: 8842419
[TBL] [Abstract][Full Text] [Related]
13. Rho-kinase inhibitor, fasudil, prevents neuronal apoptosis via the Akt activation and PTEN inactivation in the ischemic penumbra of rat brain.
Wu J; Li J; Hu H; Liu P; Fang Y; Wu D
Cell Mol Neurobiol; 2012 Oct; 32(7):1187-97. PubMed ID: 22552888
[TBL] [Abstract][Full Text] [Related]
14. A Rho kinase (ROCK) inhibitor, fasudil, prevents matrix metalloproteinase-9-related hemorrhagic transformation in mice treated with tissue plasminogen activator.
Ishiguro M; Kawasaki K; Suzuki Y; Ishizuka F; Mishiro K; Egashira Y; Ikegaki I; Tsuruma K; Shimazawa M; Yoshimura S; Iwama T; Hara H
Neuroscience; 2012 Sep; 220():302-12. PubMed ID: 22710066
[TBL] [Abstract][Full Text] [Related]
15. Fasudil, a Rho-kinase inhibitor, attenuates induction and progression of cerebral aneurysms: experimental study in rats using vascular corrosion casts.
Eldawoody H; Shimizu H; Kimura N; Saito A; Nakayama T; Takahashi A; Tominaga T
Neurosci Lett; 2010 Feb; 470(1):76-80. PubMed ID: 20043978
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotection against cerebral ischemia/reperfusion injury by intravenous administration of liposomal fasudil.
Fukuta T; Asai T; Sato A; Namba M; Yanagida Y; Kikuchi T; Koide H; Shimizu K; Oku N
Int J Pharm; 2016 Jun; 506(1-2):129-37. PubMed ID: 27107903
[TBL] [Abstract][Full Text] [Related]
17. Rho kinase inhibitor improves motor dysfunction and hypoalgesia in a rat model of lumbar spinal canal stenosis.
Ito T; Ohtori S; Hata K; Inoue G; Moriya H; Takahashi K; Yamashita T
Spine (Phila Pa 1976); 2007 Sep; 32(19):2070-5. PubMed ID: 17762807
[TBL] [Abstract][Full Text] [Related]
18. Rho-kinase activation in endothelial cells contributes to expansion of infarction after focal cerebral ischemia.
Yagita Y; Kitagawa K; Sasaki T; Terasaki Y; Todo K; Omura-Matsuoka E; Kaibuchi K; Hori M
J Neurosci Res; 2007 Aug; 85(11):2460-9. PubMed ID: 17526023
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Rho-kinase protects cerebral barrier from ischaemia-evoked injury through modulations of endothelial cell oxidative stress and tight junctions.
Gibson CL; Srivastava K; Sprigg N; Bath PM; Bayraktutan U
J Neurochem; 2014 Jun; 129(5):816-26. PubMed ID: 24528233
[TBL] [Abstract][Full Text] [Related]
20. Pleiotropic effects of the rho-kinase inhibitor fasudil after subarachnoid hemorrhage: a review of preclinical and clinical studies.
Satoh S; Ikegaki I; Kawasaki K; Asano T; Shibuya M
Curr Vasc Pharmacol; 2014; 12(5):758-65. PubMed ID: 24923440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
